McCarthy J T
Division of Nephrology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clin Proc. 1996 Feb;71(2):117-26. doi: 10.4065/71.2.117.
To determine whether any changes occurred in the complexity of illness or survival of Mayo intensive-care unit (ICU) patients with acute renal failure (ARF) who required hemodialysis between the 1977 through 1979 period and the 1991 and 1992 era.
A retrospective comparison was done of 71 consecutive ICU patients with ARF during 1977 through 1979 and 71 similar consecutive patients from the 1991 and 1992 period.
Each patient was scored for the three components of the acute physiology and chronic health evaluation (APACHE) II system (acute physiology score, age, and preexisting chronic health problems). Patient gender, postoperative status, presence of diabetes mellitus, presence of chronic renal insufficiency, and factors contributing to ARF were recorded for each patient. Patient survival and renal function at time of hospital dismissal and 12 months after initiation of hemodialysis were determined.
In comparison with patients in the earlier study period, those in the later study period had a signficantly improved rate of hospital survival (52% versus 32%) and 1-year survival (30% versus 21%). At 1 year, 96% and 78% of survivors in the earlier and later study groups, respectively, had recovery of renal function. The mean total APACHE II score was the same in both study periods, but patients in the later group were older and had more APACHE II points for chronic health problems. In the earlier and later study groups, patients with an APACHE II score of 21 or lower had a mortality rate of 36% and 11%, respectively, and survival among those with a score of 34 or greater was 0% and 15%, respectively. In 1991 and 1992, more patients had two or more factors contributing to the development of ARF, and intravenous administration of a contrast agent and preexisting cardiac prerenal compromise were more frequent causes of ARF than in 1977 through 1979. The occurrence of sepsis and preexisting lung disease were associated with a dismal prognosis in both study periods. In 1991 and 1992, survival was improved for patients with preexisting diabetes mellitus, postoperative status, and contrast-induced renal failure.
The prognosis of ICU patients with ARF has improved in more recent years, despite the fact that patients are now older, have more preexisting chronic health conditions, and have an increasing number of conditions contributing to development of ARF. The APACHE II scoring system demonstrated utility for quantifying the complexity of illness in these patients, but several important shortcomings may limit its usefulness as a comparative or prognostic tool in patients with ARF.
确定在1977年至1979年期间与1991年和1992年期间,梅奥重症监护病房(ICU)中需要血液透析的急性肾衰竭(ARF)患者的疾病复杂性或生存率是否发生了任何变化。
对1977年至1979年期间连续的71例ICU中ARF患者与1991年和1992年期间连续的71例类似患者进行回顾性比较。
对每位患者的急性生理学与慢性健康状况评估(APACHE)II系统的三个组成部分(急性生理学评分、年龄和既往慢性健康问题)进行评分。记录每位患者的性别、术后状态、糖尿病的存在、慢性肾功能不全的存在以及导致ARF的因素。确定患者出院时以及血液透析开始后12个月时的生存情况和肾功能。
与早期研究期间的患者相比,后期研究期间的患者医院生存率(52%对32%)和1年生存率(30%对21%)显著提高。1年后,早期和后期研究组分别有96%和78%的幸存者肾功能恢复。两个研究期间的平均APACHE II总分相同,但后期组的患者年龄更大,慢性健康问题的APACHE II评分更高。在早期和后期研究组中,APACHE II评分为21或更低的患者死亡率分别为36%和11%,评分为34或更高的患者生存率分别为0%和15%。在1991年和1992年,更多患者有两个或更多导致ARF发生的因素,与1977年至1979年相比,静脉注射造影剂和既往心脏肾前性损害是ARF更常见的原因。两个研究期间,脓毒症的发生和既往肺部疾病与预后不良相关。在1991年和1992年,既往有糖尿病、术后状态和造影剂诱导的肾衰竭患者的生存率有所提高。
近年来,ICU中ARF患者的预后有所改善,尽管现在患者年龄更大,既往慢性健康状况更多,且导致ARF发生的情况越来越多。APACHE II评分系统在量化这些患者的疾病复杂性方面显示出实用性,但一些重要缺点可能会限制其作为ARF患者比较或预后工具的有用性。